Based on the provided data and market context, I'll analyze whether BRK.B is overvalued through multiple lenses:
Valuation Metrics
BRK.B's current valuation shows:
- P/E ratio: 9.32x (Q3 2024)
- EV/EBITDA: 11.95x
- Price/Book: 1.58x
- Price/Sales: 2.69x
Financial Performance
- Net income has been strong and growing: $12.7B in Q1 2024, $30.3B in Q2, and $26.3B in Q3
- ROE remains healthy at 18.52% in Q3 2024
- Strong cash position with $325.2B in cash and short-term investments
{SNAPSHOT:symbol=BRK.B, type=0}
Technical Analysis
Current price is trading near its Fibonacci pivot point of $457.02, with resistance at $469.66 and support at $444.39. RSI at 52.24 indicates neutral momentum.
Conclusion
BRK.B is NOT overvalued based on its P/E ratio being significantly below market averages, strong financial performance, and Warren Buffett himself recently refraining from share buybacks due to valuation concerns. The company maintains excellent financial health with substantial cash reserves and consistent earnings growth, though current price-to-book ratio is slightly elevated compared to historical averages.